UBC Faculty Research and Publications

Vitamin C induces specific demethylation of H3K9me2 in mouse embryonic stem cells via Kdm3a/b Ebata, Kevin T; Mesh, Kathryn; Liu, Shichong; Bilenky, Misha; Fekete, Alexander; Acker, Michael G; Hirst, Martin; Garcia, Benjamin A; Ramalho-Santos, Miguel Jul 12, 2017

Your browser doesn't seem to have a PDF viewer, please download the PDF to view this item.

Item Metadata

Download

Media
52383-13072_2017_Article_143.pdf [ 1.68MB ]
Metadata
JSON: 52383-1.0366937.json
JSON-LD: 52383-1.0366937-ld.json
RDF/XML (Pretty): 52383-1.0366937-rdf.xml
RDF/JSON: 52383-1.0366937-rdf.json
Turtle: 52383-1.0366937-turtle.txt
N-Triples: 52383-1.0366937-rdf-ntriples.txt
Original Record: 52383-1.0366937-source.json
Full Text
52383-1.0366937-fulltext.txt
Citation
52383-1.0366937.ris

Full Text

Ebata et al. Epigenetics & Chromatin  (2017) 10:36 DOI 10.1186/s13072-017-0143-3RESEARCHVitamin C induces specific demethylation of H3K9me2 in mouse embryonic stem cells via Kdm3a/bKevin T. Ebata1†, Kathryn Mesh1†, Shichong Liu2, Misha Bilenky3, Alexander Fekete4, Michael G. Acker4, Martin Hirst3,5, Benjamin A. Garcia2 and Miguel Ramalho‑Santos1*Abstract Background: Histone methylation patterns regulate gene expression and are highly dynamic during development. The erasure of histone methylation is carried out by histone demethylase enzymes. We had previously shown that vitamin C enhances the activity of Tet enzymes in embryonic stem (ES) cells, leading to DNA demethylation and acti‑vation of germline genes.Results: We report here that vitamin C induces a remarkably specific demethylation of histone H3 lysine 9 dimeth‑ylation (H3K9me2) in naïve ES cells. Vitamin C treatment reduces global levels of H3K9me2, but not other histone methylation marks analyzed, as measured by western blot, immunofluorescence and mass spectrometry. Vitamin C leads to widespread loss of H3K9me2 at large chromosomal domains as well as gene promoters and repeat ele‑ments. Vitamin C‑induced loss of H3K9me2 occurs rapidly within 24 h and is reversible. Importantly, we found that the histone demethylases Kdm3a and Kdm3b are required for vitamin C‑induced demethylation of H3K9me2. Moreover, we show that vitamin C‑induced Kdm3a/b‑mediated H3K9me2 demethylation and Tet‑mediated DNA demethylation are independent processes at specific loci. Lastly, we document Kdm3a/b are partially required for the upregulation of germline genes by vitamin C.Conclusions: These results reveal a specific role for vitamin C in histone demethylation in ES cells and document that DNA methylation and H3K9me2 cooperate to silence germline genes in pluripotent cells.Keywords: Vitamin C, Histone methylation, Histone lysine demethylase, Epigenetics, Embryonic stem cells© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.BackgroundEpigenetic information encoded in chromatin is cru-cial for cell identity and differentiation [1]. One major layer of chromatin-level regulation is histone methyla-tion. In particular, histone lysine residues can be modi-fied by mono-methylation (me1), dimethylation (me2), or tri-methylation (me3). Histone methyltransferases deposit methyl groups, which can then be recognized by reader proteins that modulate gene expression [2]. Depending on the reader proteins recruited to specific methylated histone residues, the corresponding genes may be repressed or activated. For example, H3K4me3 is associated with the recruitment of factors that promote gene activation, whereas H3K9me2/3 is associated with recruitment of repressive factors. In turn, histone methyl groups are removed by histone demethylases, most of which belong to the family of Fe(II)- and 2-oxoglutar-ate-dependent dioxygenases [2, 3]. The balance of the activity of histone methylases and demethylases deter-mines the overall histone methylation patterns within a cell. Shifts in this balance underlie the extensive remod-eling of histone methylation patterns that occurs during development.The essential nutrient vitamin C has historically been described as a co-factor of collagen prolyl hydroxylases, Open AccessEpigenetics & Chromatin*Correspondence:  mrsantos@ucsf.edu †Kevin T. Ebata and Kathryn Mesh contributed equally to this work1 Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco, CA, USAFull list of author information is available at the end of the articlePage 2 of 12Ebata et al. Epigenetics & Chromatin  (2017) 10:36 the prototypical members of the family of Fe(II)- and 2-oxoglutarate-dependent dioxygenases, by recycling Fe(III) to Fe(II) [4]. The more recent discoveries that enzymes involved in DNA and histone demethylation are also Fe(II)- and 2-oxoglutarate-dependent dioxygenases [5] raises the interesting possibility that epigenetic pro-grams may be modulated by diet [6]. In support of this notion, we and others reported that vitamin C enhances the activity of Tet enzymes, which are also Fe(II)- and 2-oxoglutarate-dependent dioxygenases, leading to wide-spread DNA demethylation and a blastocyst-like state in Embryonic Stem (ES) cells [7, 8].Several studies have explored DNA methylation and his-tone mark patterning in ES cells during the transition from formative or primed (hypermethylated) to naïve (hypo-methylated) state [9–12]. This transition can be modeled in  vitro by switching ES cells maintained in serum con-taining media to a serum-free media supplemented with GSK3β and ERK1/2 inhibitors (2i) [9, 10]. In the pres-ence of 2i, ES cells show a gradual global decrease in DNA methylation and concurrent reduction of H3K9me2 while maintaining H3K9me3 [11, 12]. Additionally, the distribu-tion of H3K27me3 is globally redistributed with reduced levels at promoters in 2i [9] and accumulation at trans-posons after conversion to 2i + vitamin C [12]. Together, these studies identified a global reprogramming in DNA and histone methylation patterns during the primed to naïve state. However, the specific impact of vitamin C on histone methylation patterns and the potential interplay with DNA methylation and gene expression in ES cells maintained in the naïve (2i) state has not been investigated.We report here that vitamin C leads to a remarkably specific and global reduction of histone H3 lysine 9 di-methylation (H3K9me2) in naïve mouse ES cells. The histone demethylases Kdm3a and Kdm3b are required for vitamin C-induced H3K9me2 demethylation, in a manner that is independent of Tet-mediated DNA dem-ethylation. DNA methylation and H3K9me2 cooperated to repress germline gene expression in ES cells. These results highlight that histone methylation patterns are not indiscriminately sensitive to vitamin C. Moreover, our findings uncover a specific role for vitamin C in the epigenetic program of pluripotent cells, with implications for the regulation of germline development.ResultsVitamin C induces a specific loss of H3K9me2 in ES cellsWe used mass spectrometry to perform an unbiased quantitative analysis of H3 N-terminal post-translational modifications (PTMs) in naïve mouse ES cells with or without vitamin C treatment for 72  h. Analysis of the percentages of unmodified H3K4, H3K9, H3K27, or H3K36 revealed that only unmodified H3K9 increased significantly in vitamin C-treated ES cells (Fig. 1a). Inter-estingly, there is a concomitant reduction in H3K9me2, but not H3K9me3, upon vitamin C treatment (Fig. 1b, c). H3K9me2 is reduced about 2.6-fold in vitamin C-treated ES cells, whereas there are minimal to no changes in other H3 PTM analyzed (Fig. 1c). Western blot of H3K9 PTMs confirmed a global reduction of H3K9me2 follow-ing vitamin C treatment, while H3K9me3, H3K9me1, and H3K9ac did not show significant changes (Fig.  1d). In agreement with the mass spectrometry data, we did not observe changes by Western blot in other H3 PTMs following vitamin C treatment (Additional file  1: Figure S1A). The lack of changes in H3K9me1 suggests that vita-min C promotes demethylation of both methyl groups of H3K9me2, leading to the increase in unmodified H3K9. Alternatively, vitamin C may promote demethylation of H3K9me2 to H3K9me1 and of H3K9me1 to H3K9me0 on short time scales such that overall H3K9me1 levels are not changed. Immunofluorescence for H3K9 PTMs showed an overall decrease in H3K9me2 staining inten-sity with vitamin C treatment as well as a change from diffuse nuclear staining to a punctate staining pattern that correspond to Dapi-dense heterochromatin (Fig. 1e; Additional file 1: Figure S1B). Residual H3K9me2 at con-densed heterochromatin may be insensitive to vitamin C because it is less accessible to histone demethylases, and/or because it is a transient step on the way to H3K9me3.The histone methyltransferase G9a and its binding partner G9a-like protein (GLP) can generate H3K9me2, but not H3K9me3 [13]. We therefore compared H3K9me2 levels in vitamin C-treated ES cells to G9a−/− and GLP−/− ES cells. These mutant ES cells have almost undetectable levels of H3K9me2, a much more profound loss of this mark than that induced by vitamin C treat-ment (Additional file  2: Figure S2A). Consistent with a previous study [14], H3K9me2 in G9a−/− and GLP−/− ES cells is present in a punctate pattern similar to vitamin C treatment (Additional file 2: Figure S2B), and this mini-mal residual H3K9me2 in G9a−/− and GLP−/− ES cells is further reduced by vitamin C (Additional file 2: Figure S2A). Overall, these data suggest that vitamin C induces partial loss of H3K9me2 generated by G9a/GLP.H3K9me2 is reduced at large chromosomal domains and gene promoters in ES cells treated with vitamin CWe next examined the effect of vitamin C treatment on the genome-wide distribution of H3K9me2 at a finer resolution using chromatin immunoprecipitation (ChIP) followed by next-generation sequencing (ChIP-seq). A rescaling factor was applied to correct for greater sequencing depth in the H3K9me2 data from vitamin C-treated ES cells (Additional file 3: Figure S3, see “Meth-ods” section). The overall distribution of H3K9me2 is not Page 3 of 12Ebata et al. Epigenetics & Chromatin  (2017) 10:36 affected with vitamin C treatment (Fig. 2a), but the level of H3K9me2 signal is reduced genome-wide (Fig. 2b), con-sistent with the western blot, Immunofluorescence and mass spectrometry data. Importantly, we found that gene promoters display a generalized reduction in H3K9me2 signal in vitamin C-treated ES cells (Fig. 2c).To validate the ChIP-seq data, ChIP-qPCR for H3K9me2 was performed at promoters of germline genes that are de-repressed in ES cells following vitamin C treatment [7]. There is a two to threefold decrease in H3K9me2 in vitamin C-treated ES cells compared to untreated ES cells across all genes analyzed (Fig.  2d). A similar pattern is observed at repeat elements known to be marked by H3K9me2 (Additional file  4: Figure S4). Specificity of the ChIP was confirmed by immunopre-cipitation with anti-IgG antibody as well as a primer set for the promoter of Gapdh, which is devoid of H3K9me2 (Fig. 2d). Taken together, these results indicate that vita-min C induces a widespread loss of H3K9me2 in ES cells at large chromosomal regions, repeat elements and pro-moters of repressed germline genes.Kdm3a and Kdm3b mediate vitamin C‑induced loss of H3K9me2We next assessed the kinetics and reversibility of H3K9me2 loss upon vitamin C treatment. H3K9me2 is K9me1aK9me2K9me3K9acH3dK9me1K9me2K9me3K9acUntreated + VitCUn-treated + VitCcK9unmod 0.33K27me2 0.21K4me2 0.16K27me3 0.15K36me1 0.12K36unmod 0.05K4me1 0.05K4unmod -0.02K9me3 -0.09K27unmod -0.11K9me1 -0.23K27me1 -0.24K36me3 -0.27K36me2 -0.29K9me2 -1.280% 20% 40% 60% 80% 100% H3K4 H3K9 H3K27 H3K36 Percentage of unmodified peptide Untreated VitC Log 2 VitC/UntreatedRatio of PTMsunmod me1 me2 me3 ac H3K4unmod me1 me2 me3 ac H3K9 H3K27 H3K36be*Fig. 1 Vitamin C leads to a global reduction in H3K9me2 in ES cells. a Percentage of peptide with unmodified K4, K9, K27 or K36 residues on histone H3 from histone mass spectrometry performed on biological triplicates of untreated and vitamin C‑treated ES cells. The percentage of unmodi‑fied H3K9 is significantly increased with vitamin C treatment. Asterisk represents P < 0.05 by t test. b Pie charts displaying the prevalence of various PTMs on histone H3 K4, K9, K27 and K36 residues in untreated (blue) and vitamin C‑treated (red) ES cells. c  Log2 ratio of indicated H3 PTMs in vitamin C‑treated versus untreated ES cells. H3K9me2 shows the largest fold change and is decreased following vitamin C treatment. Unmodified H3K9 shows the largest increase. d Western blot for H3K9 PTMs in untreated and vitamin C‑treated ES cells. e Immunofluorescence for H3K9 PTMs in untreated and vitamin C‑treated ES cells. Scale bar represents 20 μmPage 4 of 12Ebata et al. Epigenetics & Chromatin  (2017) 10:36 reduced after 24 h of vitamin C treatment, with no fur-ther reduction by 72  h (Fig.  3a). The loss of H3K9me2 is reversible and returns to baseline levels 72  h after vitamin C withdrawal (Fig.  3a). We therefore explored whether vitamin C may lead to reversible loss of H3K9me2 by shifting the balance of methylation/dem-ethylation toward demethylation. Enzymes of the Kdm3 family are responsible for demethylating H3K9me1 and H3K9me2 [15]. There are three Kdm3 family members: Kdm3a, Kdm3b, and Kdm3c (also known as Jmjd1a, Jmjd1b, and Jmjd1c, respectively), although Kdm3c may not have catalytic activity [16]. Importantly, there is no change in the expression of Kdm3 family members fol-lowing vitamin C treatment (Additional file  5: Figure S5A). We tested which Kdm3 family members might be involved in vitamin C-induced H3K9me2 demethylation, using RNAi. Knockdown efficiency and specificity was confirmed by qRT-PCR (Additional file  5: Figure S5B). Knockdown of Kdm3a or Kdm3b, but not Kdm3c, atten-uated vitamin C-induced demethylation of H3K9me2 (Fig. 3b). Double knockdown of Kdm3a and Kdm3b com-pletely abolished vitamin C-induced demethylation of bac d0 4 8 12 16 20 Gapdh Magea2 Magea5 Asz1 Wfdc15a Dazl Gtsf1 Rpl39l Pdha2 Percentage of input Untreated K9me2 Untreated IgG (+) VitC K9me2 (+) VitC IgG *** ***Log10 (H3K9me2 - Untreated)Log 10 (H3K9me2 - VitC)Average signal(500bp bins genome wide)~1.4 GbGenome wide enrichment of H3K9me2Untreated(~1.60 Gb)VitC(~1.52 Gb)Log2 (VitC/Untreated)Fold change of H3K9me2 at promoters (TSS +/- 2kb)Protein coding genesFig. 2 H3K9me2 is reduced globally across the genome including at gene promoters in ES cells treated with vitamin C. a ChIP‑seq for H3K9me2 in ES cells treated with and without vitamin C was used to identify genomic regions enriched for H3K9me2. Venn diagram shows overlap of regions enriched for H3K9me2 with and without vitamin C treatment. b H3K9me2 signal genome‑wide was plotted comparing untreated and vitamin C‑treated cells. The H3K9me2 signal is reduced globally with vitamin C treatment despite an overall high correlation between the samples (Pearson correlation of ~0.98). c Sorted fold change for average H3K9me2 signal at gene promoters (TSS ± 2 kb). Most gene promoters display a reduction in H3K9me2 in vitamin C‑treated ES cells. d ChIP‑qPCR for H3K9me2 in ES cells ± vitamin C at gene promoters. ChIP for IgG was performed as a nega‑tive control. The Gapdh promoter is a negative control region devoid of H3K9me2. Data are mean ± SD. Asterisks represent P < 0.05 by t testPage 5 of 12Ebata et al. Epigenetics & Chromatin  (2017) 10:36 H3K9me2 (Fig. 3c). ChIP-qPCR for H3K9me2 confirmed that Kdm3a/3b are required for vitamin C-induced loss of H3K9me2 (Fig. 3d). Moreover, we found that vitamin C enhances the in  vitro activity of recombinant human KDM3A in demethylating a peptide at H3K9 (Fig.  3e; Additional file  6: Figure S6). These results indicate that vitamin C acts via Kdm3a/b enzymes to promote dem-ethylation of H3K9me2.Interaction between vitamin C‑induced changes in 5‑methylcytosine/5‑hydroxymethylcytosine and vitamin C‑induced reduction in H3K9me2Vitamin C has previously been shown to enhance Tet activity in ES cells leading to an increase in 5-hydrox-ymethylcytosine (5-hmC) and DNA demethylation at gene promoters [7, 8]. There is extensive cross-talk between DNA methylation and histone meth-ylation [17]. DNA demethylation could conceivably Vitamin C-8 -6 -4 -20.00.11.01.52.0log [M]Fold ActivationDTTL-Glutathione reducedL-Glutathione oxidizedK9me2H3baVitC- +Untreated- + - + - + - +NTsiRNAKdm3asiRNAKdm3bsiRNAKdm3csiRNAK9me2H3- +Untreated- + - +NTsiRNAKdm3a & 3bsiRNAVitCK9me2H30 hr 24 hr6 hr 72 hr 144 hrVitC0 hr 72 hr 144 hrcUntx Untx + VitC NT siRNA NT siRNA + VitC Kdm3a/b siRNA Kdm3a/b siRNA + VitCd0 0.5 1 1.5 2 Magea2 Magea5 Asz1 Wfdc15a Dazl Gtsf1 Rpl39l Pdha2 Fold ****e*******Fig. 3 Kdm3a and Kdm3b mediate vitamin C‑induced loss of H3K9me2. a Kinetics and reversibility of H3K9me2 loss following vitamin C treatment. H3K9me2 levels were measured by western blot at 6, 24, and 72 h following vitamin C treatment. Vitamin C was then removed, and H3K9me2 levels were measured 72 h later (144 h). b Western blot for H3K9me2 in ES cells ± vitamin C with siRNA knockdown of Kdm3 family enzymes or a non‑targeting control. c Western blot for H3K9me2 in ES cells ± vitamin C with double knockdown of Kdm3a/3b or non‑targeting control. d ChIP‑qPCR for H3K9me2 at gene promoters in ES cells ± vitamin C with double knockdown of Kdm3a/3b or non‑targeting control. Data are presented as fold change relative to the untreated control. Data are mean ± SD. Asterisks represent P < 0.05 by t test. e In vitro activity of recombinant KDM3A toward demethylation of a synthetic H3K9me1 peptide, in the presence of vitamin C, DTT or glutathione (see “Methods” section for details). Data are mean ± SD. Asterisks are P < 0.05 by t test for vitamin C compared to the oxidized form of glutathionePage 6 of 12Ebata et al. Epigenetics & Chromatin  (2017) 10:36 impact chromatin accessibility and affect the ability of H3K9me2 demethylases to act. We therefore sought to determine the interaction between vitamin C-induced changes in 5-hmC/5-mC and vitamin C-induced reduction in H3K9me2. Tet1/2 double knockout (Tet DKO) ES cells, which do not increase 5-hmC or demethylate promoters in response to vitamin C, still display a global loss of H3K9me2 following vita-min C treatment (Fig.  4a). Thus, vitamin C-induced loss of H3K9me2 can occur independently of vitamin C-induced Tet-mediated deposition of hydroxymeth-ylation. Additionally, global 5-hmC is increased fol-lowing vitamin C treatment in G9a−/− and GLP−/− ES cells to levels comparable to those in parental wild-type ES cells (Fig.  4b). Finally, we focused on ger-mline genes that lose H3K9me2 (Fig.  2d), lose DNA methylation and are induced [7] in response to vitamin C. Kdm3a/b double knockdown ES cells have a simi-lar extent of vitamin C-induced DNA demethylation as non-targeting siRNA-transfected ES cells; however, they appear to have slightly elevated baseline DNA methylation levels (Fig.  4c). These data indicate that vitamin C-induced DNA demethylation can occur independently of H3K9me2 demethylation at germline genes sensitive to vitamin C levels.Kdm3a/3b are partially required for vitamin C‑induced upregulation of germline genes in ES cellsDNA methylation and H3K9me2 are both considered repressive marks that inhibit gene expression when pre-sent at gene promoters. We previously showed that vitamin C treatment in ES cells leads to upregulation of a bVitC- + - + - +TT2 G9a KO GLP KO2-fold serial dilutions100 ngK9me2H3VitC - + - +WT Tet DKO0 10 20 30 40 50 60 Gapdh Asz1 Wfdc15a Dazl Gtsf1 Rpl39l Pdha2 Percentage of input Untreated Untreated + VitC NT siRNA NT siRNA + VitC Kdm3a/b siRNA Kdm3a/b siRNA + VitC c* *** ** * *** *** * * ***Fig. 4 Interaction between vitamin C‑induced increase in 5‑hydroxymethylation and vitamin C‑induced loss of H3K9me2. a Western blot for H3K9me2 in wild‑type and Tet1/2 double knockout (Tet DKO) ES cells ± vitamin C. Vitamin C‑induced loss of H3K9me2 still occurs in Tet DKO ES cells that do not undergo vitamin C‑induced increase in 5‑hmC. b Dot blot for 5‑hydroxymethylcytosine (5‑hmC) in wild‑type parental TT2, G9a knockout, and GLP knockout ES cells ± vitamin C. Vitamin C‑induced increase in 5‑hmC still occurs in G9a and GLP knockout ES cells depleted of H3K9me2. c meDIP‑qPCR on ES cells ± vitamin C that were untreated, treated with a non‑targeting (NT) siRNA, or treated with siRNAs against Kdm3a and Kdm3b. Vitamin C‑induced DNA demethylation occurs in the absence of Kdm3a/b and loss of H3K9me2. Data are mean ± SD. Asterisks represent P < 0.05 by t testPage 7 of 12Ebata et al. Epigenetics & Chromatin  (2017) 10:36 germline genes and that this upregulation is partially Tet-dependent [7]. Our time-course experiments indicate that loss of H3K9me2 occurs after 24 h (Fig. 3a), whereas DNA demethylation occurs more slowly and takes 72  h [7]. We sought to determine whether loss of H3K9me2 contributes to the activation of germline genes by vita-min C. First, we analyzed the kinetics of germline gene induction following vitamin C treatment, between 12 and 72 h, and found that vitamin C-induced gene induction occurs progressively over this time period (Fig. 5a). Next, we found that double knockdown of Kdm3a/b attenuates vitamin C-induced germline gene induction (Fig.  5b). Overall, these data suggest that DNA methylation and H3K9me2 are partially redundant mechanisms of repres-sion of germline genes.DiscussionWe report here that vitamin C leads to the specific and widespread loss of H3K9me2 in ES cells, via a mechanism that requires the Kdm3a/3b histone demethylases and is independent of Tet-mediated DNA demethylation. Vita-min C has also been shown to increase the efficiency of reprogramming of somatic cells to the induced pluripo-tent stem cell state, and this effect is likely mediated by both Tet enzymes and histone demethylases [18, 19].The remarkable stability of other histone marks in this study raises the possibility that not all histone demethy-lases are equally dependent on vitamin C. Although our analysis of global histone marks by Western and mass spectrometry showed a specific loss of H3K9me2, it does not exclude the possibility that vitamin C enhances the activity of other histone demethylases at a local level. a0 4 8 12 16 Fold Untx Untx + VitC NT siRNA NT siRNA + VitC Kdm3a/b siRNA Kdm3a/b siRNA + VitC 0 10 20 30 40 FoldMageA2 MageA5 Asz1 Wfdc15a Dazl Gtsf1 Rpl39l Pdha2 0 1 2 3 4 5 Nanog Asz1 Wfdc15a Dazl Gtsf1 Rpl39l Pdha2 Magea2 Magea5 0 24 48 72 Fold (Log2) HoursbFig. 5 Kdm3a and Kdm3b are partially required for upregulation of genes following vitamin C treatment. a Kinetics of gene upregulation follow‑ing vitamin C treatment.  Log2 fold change in gene expression was evaluated by qRT‑PCR at 12, 24, 48, and 72 h following vitamin C treatment. b Fold change in gene expression following vitamin C treatment with siRNA knockdown of Kdm3a/3b or non‑targeting control. Vitamin C‑induced upregulation of genes is attenuated with Kdm3a/3b knockdownPage 8 of 12Ebata et al. Epigenetics & Chromatin  (2017) 10:36 Interestingly, in contrast to the loss of H3K9me2 we observed in ES cells, vitamin C was shown to promote loss of H3K36me2/3 via KDM2A/2B in mouse embry-onic fibroblasts. These results suggest that different cell types, varying in many factors including expression levels of different histone demethylases, may affect the extent to which histone methylation patterns are sensitive by vitamin C [20]. It will be important to study the effect of vitamin C on histone methylation patterns in other cell types and investigate a potential structural basis for the differential sensitivity of histone demethylases to vitamin C.Given the genome-wide loss of H3K9me2 (this study) and DNA methylation [7] induced by vitamin C, it is interesting that the transcriptome of ES cells is largely unchanged, with the exception of a subset of germline-associated genes [7]. It is possible that other genetic programs remain silenced by other repressive mecha-nisms, such as H3K27me3 [21], which we show here is largely insensitive to vitamin C, and/or the lack of tran-scriptional activators. We found that vitamin C-induced loss of H3K9me2 is independent of Tet-mediated DNA demethylation at specific germline genes and that both H3K9me2 and DNA methylation contribute to their repression in ES cells. Our results indicate that pluripo-tent cells have the ability to express germline genes, but that these are repressed by H3K9me2 and DNA meth-ylation. Interestingly, both H3K9me2 and DNA meth-ylation are detected at high levels in pluripotent epiblast cells in  vivo and are extensively erased during germline (but not soma) development [22–25]. Moreover, meth-ods to generate germline-like cells from pluripotent stem cells in vitro involve culture in the presence of knockout serum replacement (KSR), which contains vitamin C [26, 27]. It will be of interest to assess whether vitamin C reg-ulates H3K9me2, DNA methylation or gene expression during germline development, in vivo or in vitro. In addi-tion, our results raise the possibility that vitamin C avail-ability may regulate other processes where H3K9me2 has been shown to play a role, such as in hematopoietic lin-eage commitment [28], brain development [29] or adult metabolism [30].ConclusionsIn this study, we investigated the role of vitamin C in regulating histone methylation in naïve ES cells. We per-formed comprehensive profiling of histone methylation by mass spectrometry following vitamin C treatment and found a specific reduction in H3K9me2. The distri-bution pattern of H3K9me2 was not changed by vitamin C, instead levels were reduced throughout the genome, including at gene promoters. Mechanistic studies showed that vitamin C-induced loss of H3K9me2 is via Kdm3a/b enzymes. Vitamin C reduces both H3K9me2 and DNA methylation independently at germline gene promoters, allowing expression of these genes in ES cells.MethodsES cell lines and cell cultureOct4-GiP, TT2, G9a−/−, GLP−/−, V6.5, and Tet1−/− Tet2−/− ES cells were used in this study. ES cells were cultured on tissue culture plates coated with 0.1% gela-tin in 2i medium, which consists of N2B27 base medium [31] supplemented with the MEK inhibitor, PD0325901 (1  μM, Stemgent), the GSK3β inhibitor, CHIR99021 (3  μM, Selleck Chemicals), and with ESGRO leukemia inhibitory factor (LIF) at 1000  U/ml (Millipore). Vita-min C (L-ascorbic acid 2-phosphate, Sigma, A8960) was added on day 1 after seeding at 100 μg/ml. Medium was replaced daily.ImmunofluorescenceCultured cells were fixed in 4% paraformaldehyde for 15  min, washed 3× with PBS, and blocked with block-ing solution (PBS + 0.5% Tween20 + 5% FBS) for 1 h at room temperature (RT). Primary antibodies were diluted in blocking solution and incubated with cells overnight at 4  °C. Primary antibodies included H3K9ac (1:1000, Active Motif, 39917), H3K9me1 (1:2000, Abcam, ab9045), H3K9me2 (1:1000, Abcam, ab1220), H3K9me3 (1:1000, Diagenode, pAb-056-050). Cells were then washed for 5 min 3× in PBS and incubated with secondary antibod-ies in blocking solution for 2 h at RT. Secondary antibod-ies included 594-conjugated donkey anti-mouse (1:1000, Life Technologies, A21203) and 594-conjugated donkey anti-rabbit (1:1000, Life Technologies, A21207). DAPI (1  μg/ml) was added with secondary antibodies. Cells were washed for 5 min 3× in PBS prior to imaging.Histone extraction for quantitative mass spectrometry and Western blottingCore histones were extracted from cultured ES cells using the Histone Purification Mini Kit (Active Motif, 40026). Following extraction, core histones were precipitated in 4% perchloric acid overnight at 4 °C, washed, and resus-pended in water.Western blotIsolated histones were resolved on a 4–20% gradient TGX gel and transferred to PVDF membranes. Mem-branes were blocked in blocking solution (Li-Cor Odys-sey Buffer diluted 1:1 with PBS) for 1  h at RT. Primary antibodies were diluted in blocking solution and incu-bated for 3 h at RT. Membranes were washed for 10 min 3× in TBST (TBS  +  0.5% Tween) and incubated with secondary antibodies diluted in blocking solution for 2 h Page 9 of 12Ebata et al. Epigenetics & Chromatin  (2017) 10:36 at RT. Membranes were washed for 10 min 3× in TBST and visualized with Pierce ECL Plus.Quantitative mass spectrometry (qMS)Approximately 20  μg of extracted histones was resus-pended in 30  μl of 100  mM ammonium bicarbonate, at pH 8.0. Chemical propionylation derivatization, digestion and desalting of histones followed by analysis by LC–MS and MS/MS were performed as described previously [32, 33]. In brief, purified peptides were loaded onto 75-μm-ID fused-silica capillary columns packed with 12  cm of C18 reversed-phase resin (Reprosil-pur 120 C18, aq-3 μm particles, Fisher Scientific). Peptides were sepa-rated using EASY-nLC nano-HPLC (Thermo Scientific, Odense, Denmark) and introduced into a hybrid linear quadrupole ion trap–Orbitrap mass spectrometer (Ther-moElectron) and resolved with a gradient from 0 to 35% solvent B (A = 0.1% formic acid; B = 95% MeCN, 0.1% formic acid) over 30  min and from 34 to 100% solvent B in 20 min at a flow-rate of 250 nL/min. The Orbitrap was operated in data-dependent mode essentially as pre-viously described [33]. Relative abundances of peptide species were calculated by chromatographic peak inte-gration of full MS scans using EpiProfile [34]. Where nec-essary, peptide and PTM identity were verified by manual inspection of MS/MS spectra.Chromatin immunoprecipitationIsolated ES cells were resuspended in PBS and crosslinked with 1% formaldehyde for 5 min at RT. Crosslinking was quenched with 125 mM glycine. Crosslinked material was sonicated on a Covaris sonicator for 12  min at duty 5%, intensity 3, and bursts 200. ChIP was performed using the Diagenode LowCell# Kit with a mouse anti-H3K9me2 antibody (Abcam, ab1220). A mouse anti-IgG antibody (Abcam, ab18413) was used as control. Isolated DNA was used for qPCR analysis with the KAPA SYBR Fast  ABI Prism qPCR kit on an Applied BioSystems 7900HT Sequence Detection System. Primer sequences are listed in Additional file 7: Table S1. For ChIP-seq isolated DNA was resuspended in an elution buffer (10  mM Tris–HCl pH 7.6, 200 mM NaCl, 5 mM EDTA, 0.5% SDS) with 10 μl RNAse and reverse-cross-linked at 65 °C for 4 h. Protein-ase K was added and samples were incubated at 55 °C for 1 h. DNA was purified with QIAquick and quantified with a Qubit Fluorometer (Invitrogen). ChIP-seq libraries were constructed from immunoprecipitated DNA as described [35]. Libraries were sequenced using paired-end 100nt sequencing V3 chemistry on an HiSeq  2000 sequencer following the manufacturer’s protocols (Illumina, Hay-ward, CA.) using multiplex custom index adapters added during library construction to distinguish pooled samples.Dot blot analysisDot blot analysis was performed as previously described [7]. Briefly, isolated DNA was denatured and then seri-ally diluted twofold. DNA samples were spotted on a nitrocellulose membrane using a Bio-Dot apparatus (Bio-Rad) and immunoblotted with rabbit anti-5-hy-droxymethylcytosine polyclonal antibody (Active Motif, 1:5000) in Odyssey:PBS (Li-Cor). The membrane was washed and then incubated with HRP-conjugated goat anti-rabbit IgG (Abcam, 1:10,000) secondary antibody in Odyssey:PBS. The membrane was visualized by chemilu-minescence with GE ECL Plus.5mC DNA immunoprecipitationDNA immunoprecipitation was performed using the Diagenode MagMeDIP as previously described [7]. Briefly, DNA was sonicated into short fragments with a Diagenode Bioruptor. Sonicated DNA (1 μg) was immu-noprecipitated with 1 μg of mouse anti-5-methylcytosine monoclonal antibody (Active Motif, 1 μg/μl). Isolation of immunoprecipitated DNA was performed according to the kit instructions, and qPCR was performed in com-bination with the KAPA SYBR Fast ABI Prism qPCR kit on an Applied BioSystems 7900HT Sequence Detection System. Primer sequences are listed in Additional file 7: Table S1.qRT‑PCRTotal RNA was isolated from cultured cells using Qiagen RNeasy with on-column DNase I treatment. cDNA was generated from 1 μg of RNA using random hexamers to prime the reaction. Quantitative RT-PCR was performed with the KAPA SYBR Fast  ABI Prism qPCR kit on an Applied BioSystems 7900HT sequence detection system. Primer sequences are listed in Additional file 7: Table S1. The relative amount of each gene was normalized using two housekeeping genes (L7 and Ubb), unless otherwise indicated.siRNA transfectionOct4-GiP ES cells were transfected in suspension with Dharmacon siGENOME SMARTpool siRNAs (4 siRNAs per gene) against Kdm3a, Kdm3b, or Kdm3c at 50  nM and seeded into tissue culture plates (Day 0). Cells were re-transfected on day 2 followed by treatment with vita-min C for 24 or 72 h. For double knockdown of Kdm3a and Kdm3b, cells were transfected with 50  nM of both Kdm3a and Kdm3b siRNAs for a total final concentra-tion of 100  nM. Dharmacon siGENOME non-targeting siRNA (NT2) was used as a control. Dharmafect reagent was used for transfections according to manufacturer’s instructions.Page 10 of 12Ebata et al. Epigenetics & Chromatin  (2017) 10:36 KDM3a biochemical assayThe KDM3A assay was performed in 384-well black flat-bottom plates (Corning, Cat# 3654). Enzyme and substrate solutions were prepared in assay buffer consisting of 5 mM HEPES pH 7.0, 15 mM HEPES pH 7.5, 25 mM NaCl, 1 µM (or 1  mM) Alpha-ketoglutarate, 3.75  µM  FeSO4, 0.014% Tween 20, 0.03% BSA. Dose–response concentrations of vitamin C (MP Biochemicals, 100769), DTT (Sigma, D0632) or glutathione (Affymetrix, 16315; Chem-Impex, 00158) were as indicated in the graphs. The KDM3A enzyme was produced in house [16]. H3K9me1 substrate was purchased from Perkin Elmer. Plates were covered and incubated for 30 min at room temperature. The reac-tion is stopped with detection buffer consisting of 100 mM HEPES pH 7.0, 800 mM KF and 0.2% BSA containing the detection reagents Eu-antiH3K9me0 (purchased from Per-kin Elmer) and SA:APC (i.e., XL-665, purchased from Cis-bio). The final concentrations of the various reagents were: KDM3A 2  nM, H3K9me1 500  nM, Eu-antiH3K9me0 0.75 nM, SA:APC 1.67 µg/ml. Plates were read in a Perkin Elmer Envision Plate Reader (ex/em 340/615 and 340/665).BioinformaticsChIP-seq raw sequences were examined for quality, sam-ple swap and reagent contamination using custom in house scripts. Sequence reads were aligned to mm10 using BWA 0.5.7 and default parameters and assessed for overall quality using Findpeaks 3.1 [36]. For rescaling, we calculated average ChIP-seq coverage in 500 bp genomic bins. We considered ~150 bins with the highest signal in untreated data samples and calculated distributions of the fold change between vitamin C-treated and untreated data. These bins typically correspond to alignment arti-facts and have extreme coverage not due to enrichment. They appear in both IP and control data sets with a very similar coverage profile, as validated by visual inspection of the majority of those locations in the UCSC genome browser. The alignment artifacts have a universal nature (mostly due to incomplete knowledge of genome) with the expectation that for similar cell types and the same read length and DNA fragment length distributions, the differ-ence in the coverage for these ‘outliers’ will be a reflection of the differences in the sequencing depth. We observed that, as expected, for the input sample, the fold change for the total genomic coverage between vitamin C-treated and untreated data is in agreement with median fold change measured from ‘outliers’ bins. For the H3K9me2 signal, these twofold change values are very different, and for the ‘outliers’ the fold change is larger than a value of 1, suggest-ing that vitamin C-treated data had to be rescaled with a factor ~0.57 (Additional file  3: Figure S3). We verified that the value for the scaling factor depends only weakly on the exact threshold for choice of the outliers within a reasonable range. Using the rescaled data, the coverage profiles for DNA fragments corresponding to properly paired aligned reads were calculated and used to deter-mine the average coverage in 500  bp bins genome wide (5,459,336 bins) and in the promoter regions (TSS ± 2 Kb) of the coding genes (21,958 genes, Ensembl v81).Author contributionsM.R.‑S. directed the study. K.T.E. and K.M. designed and performed experi‑ments. K.T.E., K.M. and M.R.‑S. analyzed and interpreted the data. M.B. and M.H. developed and performed ChIP sequencing data processing. S.L. and B.A.G. Additional filesAdditional file 1: Figure S1.Evaluation of changes in H3 PTMs following vitamin C treatment. A) Western blot for several H3 PTMs in ES cells ± vita‑min C. B) Immunofluorescence for H3K9me2 and corresponding DAPI staining in untreated and vitamin C‑treated ES cells. Merged images show H3K9me2 in green and DAPI staining in red. H3K9me2 immunofluores‑cence is also shown in Fig. 1e. Scale bar represents 20 μm.Additional file 2: Figure S2. Analysis of H3K9me2 in G9a and GLP knockout ES cells treated with vitamin C. A) Western blot for H3K9me2 in wild‑type parental TT2, G9a knockout, and GLP knockout ES cells ± vita‑min C. B) Immunofluorescence for H3K9me2 in GiP ES cells ± vitamin C and untreated wild‑type TT2, G9a knockout, and GLP knockout ES cells. GiP ES cells treated with vitamin C show a H3K9me2 staining pattern that is similar to G9a and GLP knockout ES cells. Scale bar represents 20 μm.Additional file 3: Figure S3. Differences in sequencing between untreated and vitamin C‑treated H3K9me2 ChIP‑seq samples. Average coverage in 500 bp bins was calculated for H3K9me2 ChIP‑seq and DNA input samples. The top 150 bins with the highest signal in untreated samples were used to calculate distributions of the fold change between vitamin C‑treated and untreated data. These bins with high signal typically correspond to alignment artifacts (see “Methods” section). As expected for the Input sample, the fold change for the total genomic coverage between vitamin C‑treated and untreated data is in agreement with the median fold change measured for the outlier top 150 bins. For the H3K9me2 ChIP‑seq samples, the difference between the twofold changes suggests that the vitamin C sequencing data has to be rescaled with a factor of ~0.57.Additional file 4: Figure S4. Analysis of H3K9me2 at repetitive ele‑ments in ES cells treated with vitamin C. ChIP‑qPCR for H3K9me2 in ES cells ± vitamin C at the repetitive element families indicated. ChIP for IgG was performed as a negative control. Data are mean ± SD. Asterisks represent P < 0.05 by t test.Additional file 5: Figure S5. Effect of vitamin C treatment and siRNA knockdown on the expression of Kdm enzymes. A) Expression of Kdm family enzymes as a percentage of housekeeping gene in ES cells ± vita‑min C. B) Gene expression levels of Kdm3a, Kdm3b, and Kdm3c following siRNA knockdown. Data are presented as fold change relative to the untreated control. A non‑targeting (NT) siRNA was also used as a control. Each siRNA was applied in the presence or absence of vitamin C to show that vitamin C treatment does not affect knockdown efficiency.Additional file 6: Figure S6. Effect of α‑ketoglutarate on recombinant KDM3A activity with vitamin C, DTT and glutathione. In vitro activity of recombinant KDM3A toward demethylation of a synthetic H3K9me1 peptide, in the presence of vitamin C, DTT or glutathione, at 1 μM α‑KG (see “Methods” section for details). At this lower concentration of α‑KG, both vitamin C and DTT can enhance activity of KDM3A, but the effect of DTT saturates, whereas vitamin C does not. Data are mean ± SD. Asterisks represent P < 0.05 by t test for vitamin C compared to the oxidized form of Glutahione.Additional file 7: Table S1. Primer list.Page 11 of 12Ebata et al. Epigenetics & Chromatin  (2017) 10:36 performed histone methylation quantitative mass spectrometry and analysis. A.F. and M.A. performed in vitro histone demethylation assays. K.T.E., K.M., and M.R.‑S. wrote the manuscript with input from all the authors. All authors read and approved the final manuscript.Author details1 Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco, CA, USA. 2 Epigenetics Program, Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. 3 Cana‑da’s Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, Canada. 4 Novartis Institutes for Biomedical Research, Cambridge, MA, USA. 5 Department of Microbiology and Immunology, Centre for High‑Throughput Biology, University of British Columbia, Vancouver, BC, Canada. AcknowledgementsWe thank Matthew C. Lorincz and Yoichi Shinkai for TT2, G9a−/−, GLP−/− and M.M. Dawlaty and R. Jaenisch for the V6.5, Tet1−/− Tet2−/− ES cells.Competing interestsThe authors declare that they have no competing interests.Availability of data and materialsThe ChiP‑seq datasets used in this study have been deposited in the Gene Expression Omnibus under the accession number GSE84009. Correspondence and requests for materials should be addressed to M.R.‑S. (mrsantos@ucsf.edu).Ethics approval and consent to participateNot applicable.FundingThis work was supported by NIH Grant R01GM110174 to B.A.G., Grants CCSRI 22R22583 and TFRI NI 22R22545 to M.H., and by NIH Grants R01OD012204 and R01GM113014 to M.R.‑S.Publisher’s NoteSpringer Nature remains neutral with regard to jurisdictional claims in pub‑lished maps and institutional affiliations.Received: 2 April 2017   Accepted: 3 July 2017References 1. Mohn F, Weber M, Rebhan M, Roloff TC, Richter J, Stadler MB, Bibel M, Schübeler D. Lineage‑specific polycomb targets and de novo DNA meth‑ylation define restriction and potential of neuronal progenitors. Mol Cell. 2008;30:755–66. 2. Black JC, Van Rechem C, Whetstine JR. Histone lysine methylation dynamics: establishment, regulation, and biological impact. Mol Cell. 2012;48:491–507. 3. Klose RJ, Kallin EM, Zhang Y. JmjC‑domain‑containing proteins and histone demethylation. Nat Rev Genet. 2006;7:715–27. 4. Du J, Cullen JJ, Buettner GR. Ascorbic acid: chemistry, biology and the treatment of cancer. Biochim Biophys Acta. 2012;1826:443–57. 5. Horton JR, Upadhyay AK, Qi HH, Zhang X, Shi Y, Cheng X. Enzymatic and structural insights for substrate specificity of a family of jumonji histone lysine demethylases. Nat Struct Mol Biol. 2009;17:38–43. 6. Monfort A, Wutz A. Breathing‑in epigenetic change with vitamin C. EMBO Rep. 2013;14:337–46. 7. Blaschke K, Ebata KT, Karimi MM, Zepeda‑Martínez JA, Goyal P, Mahapatra S, Tam A, Laird DJ, Hirst M, Rao A, Lorincz MC, Ramalho‑Santos M. Vitamin C induces Tet‑dependent DNA demethylation and a blastocyst‑like state in ES cells. Nature. 2013;500:222–6. 8. Yin R, Mao S‑Q, Zhao B, Chong Z, Yang Y, Zhao C, Zhang D, Huang H, Gao J, Li Z, Jiao Y, Li C, Liu S, Wu D, Gu W, Yang Y‑G, Xu G‑L, Wang H. Ascorbic acid enhances tet‑mediated 5‑methylcytosine oxidation and promotes DNA demethylation in mammals. J Am Chem Soc. 2013;135:10396–403. 9. Marks H, Kalkan T, Menafra R, Denissov S, Jones K, Hofemeister H, Nichols J, Kranz A, Francis Stewart A, Smith A, Stunnenberg HG. The transcrip‑tional and epigenomic foundations of ground state pluripotency. Cell. 2012;149:590–604. 10. Leitch HG, McEwen KR, Turp A, Encheva V, Carroll T, Grabole N, Mansfield W, Nashun B, Knezovich JG, Smith A, Surani MA, Hajkova P. Naive pluri‑potency is associated with global DNA hypomethylation. Nat Struct Mol Biol. 2013;20:311–6. 11. von Meyenn F, Iurlaro M, Habibi E, Liu NQ, Salehzadeh‑Yazdi A, Santos F, Petrini E, Milagre I, Yu M, Xie Z, Kroeze LI, Nesterova TB, Jansen JH, Xie H, He C, Reik W, Stunnenberg HG. Impairment of DNA methylation main‑tenance is the main cause of global demethylation in naive embryonic stem cells. Mol Cell. 2016;62:848–61. 12. Walter M, Teissandier A, Pérez‑Palacios R, Bourc’his D. An epigenetic switch ensures transposon repression upon dynamic loss of DNA meth‑ylation in embryonic stem cells. Elife. 2016;5:e11418. 13. Tachibana M, Ueda J, Fukuda M, Takeda N, Ohta T, Iwanari H, Sakihama T, Kodama T, Hamakubo T, Shinkai Y. Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3‑K9. Genes Dev. 2005;19:815–26. 14. Tachibana M, Sugimoto K, Nozaki M, Ueda J, Ohta T, Ohki M, Fukuda M, Takeda N, Niida H, Kato H, Shinkai Y. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev. 2002;16:1779–91. 15. Yamane K, Toumazou C, Tsukada Y‑I, Erdjument‑Bromage H, Tempst P, Wong J, Zhang Y. JHDM2A, a JmjC‑containing H3K9 demethyl‑ase, facilitates transcription activation by androgen receptor. Cell. 2006;125:483–95. 16. Brauchle M, Yao Z, Arora R, Thigale S, Clay I, Inverardi B, Fletcher J, Taslimi P, Acker MG, Gerrits B, Voshol J, Bauer A, Schübeler D, Bouwmeester T, Ruffner H. Protein complex interactor analysis and differential activity of KDM3 subfamily members towards H3K9 methylation. PLoS ONE. 2013;8:e60549. 17. Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet. 2009;10:295–304. 18. Chen J, Liu H, Liu J, Qi J, Wei B, Yang J, Liang H, Chen Y, Chen J, Wu Y, Guo L, Zhu J, Zhao X, Peng T, Zhang Y, Chen S, Li X, Li D, Wang T, Pei D. H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs. Nat Genet. 2013;45:34–42. 19. Hu X, Zhang L, Mao S‑Q, Li Z, Chen J, Zhang R‑R, Wu H‑P, Gao J, Guo F, Liu W, Xu G‑F, Dai H‑Q, Shi YG, Li X, Hu B, Tang F, Pei D, Xu G‑L. Tet and TDG mediate DNA demethylation essential for mesenchymal‑to‑epithelial transition in somatic cell reprogramming. Cell Stem Cell. 2014;14:512–22. 20. Wang T, Chen K, Zeng X, Yang J, Wu Y, Shi X, Qin B, Zeng L, Esteban MA, Pan G, Pei D. The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin‑C‑dependent manner. Cell Stem Cell. 2011;9:575–87. 21. Boyer LA, Plath K, Zeitlinger J, Brambrink T, Medeiros LA, Lee TI, Levine SS, Wernig M, Tajonar A, Ray MK, Bell GW, Otte AP, Vidal M, Gifford DK, Young RA, Jaenisch R. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nat Cell Biol. 2006;441:349–53. 22. Hajkova P, Erhardt S, Lane N, Haaf T, El‑Maarri O, Reik W, Walter J, Surani MA. Epigenetic reprogramming in mouse primordial germ cells. Mech Dev. 2002;117:15–23. 23. Seki Y, Hayashi K, Itoh K, Mizugaki M, Saitou M, Matsui Y. Extensive and orderly reprogramming of genome‑wide chromatin modifications associ‑ated with specification and early development of germ cells in mice. Dev Biol. 2005;278:440–58. 24. Seki Y, Yamaji M, Yabuta Y, Sano M, Shigeta M, Matsui Y, Saga Y, Tachibana M, Shinkai Y, Saitou M. Cellular dynamics associated with the genome‑wide epigenetic reprogramming in migrating primordial germ cells in mice. Development. 2007;134:2627–38. 25. Seisenberger S, Peat JR, Reik W. Conceptual links between DNA methyla‑tion reprogramming in the early embryo and primordial germ cells. Curr Opin Cell Biol. 2013;25:281–8. 26. Hayashi K, Ohta H, Kurimoto K, Aramaki S, Saitou M. Reconstitution of the mouse germ cell specification pathway in culture by pluripotent stem cells. Cell. 2011;146:519–32.Page 12 of 12Ebata et al. Epigenetics & Chromatin  (2017) 10:36 •  We accept pre-submission inquiries •  Our selector tool helps you to find the most relevant journal•  We provide round the clock customer support •  Convenient online submission•  Thorough peer review•  Inclusion in PubMed and all major indexing services •  Maximum visibility for your researchSubmit your manuscript atwww.biomedcentral.com/submitSubmit your next manuscript to BioMed Central and we will help you at every step: 27. Irie N, Weinberger L, Tang WWC, Kobayashi T, Viukov S, Manor YS, Dietmann S, Hanna JH, Surani MA. SOX17 is a critical specifier of human primordial germ cell fate. Cell. 2015;160:253–68. 28. Chen X, Skutt‑Kakaria K, Davison J, Ou Y‑L, Choi E, Malik P, Loeb K, Wood B, Georges G, Torok‑Storb B, Paddison PJ. G9a/GLP‑dependent histone H3K9me2 patterning during human hematopoietic stem cell lineage commitment. Genes Dev. 2012;26:2499–511. 29. Tsukada Y‑I, Ishitani T, Nakayama KI. KDM7 is a dual demethylase for histone H3 Lys 9 and Lys 27 and functions in brain development. Genes Dev. 2010;24:432–7. 30. Inagaki T, Tachibana M, Magoori K, Kudo H, Tanaka T, Okamura M, Naito M, Kodama T, Shinkai Y, Sakai J. Obesity and metabolic syndrome in histone demethylase JHDM2a‑deficient mice. Genes Cells. 2009;14:991–1001. 31. Ying Q‑L, Wray J, Nichols J, Batlle‑Morera L, Doble B, Woodgett J, Cohen P, Smith A. The ground state of embryonic stem cell self‑renewal. Nature. 2008;453:519–23. 32. Lin S, Garcia BA. Examining histone posttranslational modification patterns by high‑resolution mass spectrometry. Meth Enzymol. 2012;512:3–28. 33. Sridharan R, Gonzales‑Cope M, Chronis C, Bonora G, McKee R, Huang C, Patel S, Lopez D, Mishra N, Pellegrini M, Carey M, Garcia BA, Plath K. Proteomic and genomic approaches reveal critical functions of H3K9 methylation and heterochromatin protein‑1γ in reprogramming to pluripotency. Nat Cell Biol. 2013;15:872–82. 34. Yuan Z‑F, Lin S, Molden RC, Cao X‑J, Bhanu NV, Wang X, Sidoli S, Liu S, Garcia BA. Epiprofile quantifies histone peptides with modifications by extracting retention time and intensity in high‑resolution mass spectra. Mol Cell Proteomics. 2015;14:1696–707. 35. Gascard P, Bilenky M, Sigaroudinia M, Zhao J, Li L, Carles A, Delaney A, Tam A, Kamoh B, Cho S, Griffith M, Chu A, Robertson G, Cheung D, Li I, Heravi‑Moussavi A, Moksa M, Mingay M, Hussainkhel A, Davis B, Nagarajan RP, Hong C, Echipare L, O’Geen H, Hangauer MJ, Cheng JB, Neel D, Hu D, McManus MT, Moore R, et al. Epigenetic and transcriptional determinants of the human breast. Nat Commun. 2015;6:6351. 36. Fejes AP, Robertson G, Bilenky M, Varhol R, Bainbridge M, Jones SJM. Find‑Peaks 3.1: a tool for identifying areas of enrichment from massively paral‑lel short‑read sequencing technology. Bioinformatics. 2008;24:1729–30.

Cite

Citation Scheme:

        

Citations by CSL (citeproc-js)

Usage Statistics

Share

Embed

Customize your widget with the following options, then copy and paste the code below into the HTML of your page to embed this item in your website.
                        
                            <div id="ubcOpenCollectionsWidgetDisplay">
                            <script id="ubcOpenCollectionsWidget"
                            src="{[{embed.src}]}"
                            data-item="{[{embed.item}]}"
                            data-collection="{[{embed.collection}]}"
                            data-metadata="{[{embed.showMetadata}]}"
                            data-width="{[{embed.width}]}"
                            async >
                            </script>
                            </div>
                        
                    
IIIF logo Our image viewer uses the IIIF 2.0 standard. To load this item in other compatible viewers, use this url:
https://iiif.library.ubc.ca/presentation/dsp.52383.1-0366937/manifest

Comment

Related Items